PSYENCE BIOMEDICAL LTD.
Calidad de datos: 17%
$2.51
▲
$0.02
(0.80%)
Cap. Mercado: 5.76 M
Precio
$2.51
Cap. Mercado
5.76 M
Rango del Día
$2.41 — $2.57
Rango de 52 Semanas
$1.92 — $468.36
Volumen
24,200
Apertura $2.48
Promedio 50D / 200D
$2.85
12.01% below
Promedio 50D / 200D
$94.91
97.36% below
Quick Summary
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A
Valoración
P/E Ratio
N/A
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Historial de Precios
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | — | -2.0 |
| P/B | — | 5.1 |
| ROE % | — | -51.0 |
| Net Margin % | — | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
ETFs Holding This Stock
0.10% weight
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | N/A |
| ROE | N/A | ROA | N/A |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | N/A |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | N/A |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | N/A | Tangible Book Value | N/A |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | N/A | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | N/A | ||
| Market Cap | 5.76 M | Enterprise Value | N/A |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | N/A | OCF / Share | N/A |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | N/A |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
{"event":"ticker_viewed","properties":{"ticker":"PBM","listing_kind":"stock","pathname":"/stocks/pbm","exchange":"Nasdaq","country":"US"}}
